Ocular hypotensive effect of the novel EP3/FP agonist ONO-9054 versus Xalatan: Results of a 28-day, double-masked, randomised study

Eydie Miller Ellis, Michael S. Berlin, Caroline L. Ward, John A. Sharpe, Alam Jamil, Alon Harris

Research output: Contribution to journalArticle

6 Scopus citations

Fingerprint Dive into the research topics of 'Ocular hypotensive effect of the novel EP3/FP agonist ONO-9054 versus Xalatan: Results of a 28-day, double-masked, randomised study'. Together they form a unique fingerprint.

Medicine & Life Sciences